These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683 [TBL] [Abstract][Full Text] [Related]
25. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke. Yu G; Wu F; Wang ES Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006 [TBL] [Abstract][Full Text] [Related]
26. Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds. Cai SX Curr Top Med Chem; 2006; 6(7):651-62. PubMed ID: 16719807 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection. Radenovic L; Selakovic V Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172 [TBL] [Abstract][Full Text] [Related]
28. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Lipton SA Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913 [TBL] [Abstract][Full Text] [Related]
29. Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial. Morris GF; Juul N; Marshall SB; Benedict B; Marshall LF Neurosurgery; 1998 Dec; 43(6):1369-72; discussion 1372-4. PubMed ID: 9848851 [TBL] [Abstract][Full Text] [Related]
30. Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury. Suma T; Koshinaga M; Fukushima M; Kano T; Katayama Y Neurol Res; 2008 May; 30(4):420-9. PubMed ID: 18248696 [TBL] [Abstract][Full Text] [Related]
35. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? Buchan AM Cerebrovasc Brain Metab Rev; 1990; 2(1):1-26. PubMed ID: 2144995 [TBL] [Abstract][Full Text] [Related]
36. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Palmer GC Curr Drug Targets; 2001 Sep; 2(3):241-71. PubMed ID: 11554551 [TBL] [Abstract][Full Text] [Related]
37. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Jansen M; Dannhardt G Eur J Med Chem; 2003; 38(7-8):661-70. PubMed ID: 12932897 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury. Golding EM; Vink R Mol Chem Neuropathol; 1995; 24(2-3):137-50. PubMed ID: 7632318 [TBL] [Abstract][Full Text] [Related]
40. Novel approach to the role of NMDA receptors in traumatic brain injury. Shohami E; Biegon A CNS Neurol Disord Drug Targets; 2014; 13(4):567-73. PubMed ID: 24168367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]